VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $632 | -63.1% | 67,442 | -3.4% | 0.00% | -66.7% |
| Q2 2023 | $1,712 | +5.5% | 69,784 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,623 | -19.0% | 69,784 | -11.9% | 0.00% | -40.0% |
| Q4 2022 | $2,003 | -99.9% | 79,168 | -7.2% | 0.01% | +25.0% |
| Q3 2022 | $1,644,000 | -23.9% | 85,298 | +0.6% | 0.00% | -33.3% |
| Q2 2022 | $2,159,000 | -1.0% | 84,775 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $2,180,000 | -39.2% | 84,775 | -1.0% | 0.01% | -37.5% |
| Q4 2021 | $3,584,000 | -5.6% | 85,620 | -1.9% | 0.01% | -20.0% |
| Q3 2021 | $3,796,000 | -27.2% | 87,241 | -20.9% | 0.01% | -23.1% |
| Q2 2021 | $5,216,000 | +13.8% | 110,329 | +23.4% | 0.01% | 0.0% |
| Q1 2021 | $4,584,000 | +16.6% | 89,428 | -39.1% | 0.01% | +8.3% |
| Q4 2020 | $3,931,000 | -22.3% | 146,804 | -0.3% | 0.01% | -29.4% |
| Q3 2020 | $5,057,000 | -22.6% | 147,318 | -7.6% | 0.02% | -32.0% |
| Q2 2020 | $6,532,000 | – | 159,439 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |